Zimmer Biomet Holdings Stock Analysis

Zimmer Stock Analysis Notes

About 94.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.78. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zimmer Biomet Holdings has Price/Earnings To Growth (PEG) ratio of 1.52. The entity last dividend was issued on the 31st of March 2025. The firm had 103:100 split on the 1st of March 2022. Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people. For more information please call Bryan Hanson at 574 373 3333 or visit https://www.zimmerbiomet.com.

Zimmer Biomet Holdings Investment Alerts

Zimmer Biomet Holdings Upcoming and Recent Events

Zimmer Largest EPS Surprises

View All Earnings Estimates

Zimmer Biomet Environmental, Social, and Governance (ESG) Scores

Zimmer Biomet Thematic Classifications

Zimmer Stock Institutional Investors

Note, although Zimmer Biomet's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Zimmer Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 22.14 B.

Zimmer Profitablity

The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.23 %, which entails that for every 100 dollars of revenue, it generated $0.23 of operating income.

Management Efficiency

Zimmer Biomet Holdings has Return on Asset of 0.0465 % which means that on every $100 spent on assets, it made $0.0465 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0725 %, implying that it generated $0.0725 on every 100 dollars invested. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities. The Zimmer Biomet's current Return On Tangible Assets is estimated to increase to 0.17, while Return On Capital Employed is projected to decrease to 0.06. As of now, Zimmer Biomet's Asset Turnover is decreasing as compared to previous years.

Technical Drivers

As of the 25th of March, Zimmer Biomet maintains the Market Risk Adjusted Performance of 0.5513, downside deviation of 1.6, and Mean Deviation of 1.14. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zimmer Biomet Holdings, as well as the relationship between them.

Zimmer Biomet Holdings Price Movement Analysis

Zimmer Biomet Holdings Insider Trading Activities

Zimmer Biomet Outstanding Bonds

Zimmer Biomet Predictive Daily Indicators

Zimmer Biomet Corporate Filings

Zimmer Biomet Forecast Models

Zimmer Biomet's time-series forecasting models are one of many Zimmer Biomet's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zimmer Biomet's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Zimmer Biomet prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zimmer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Zimmer Biomet. By using and applying Zimmer Stock analysis, traders can create a robust methodology for identifying Zimmer entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Zimmer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Zimmer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Zimmer Biomet Holdings stock analysis indicators help investors evaluate how Zimmer Biomet stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Zimmer Biomet shares will generate the highest return on investment. By understating and applying Zimmer Biomet stock analysis, traders can identify Zimmer Biomet position entry and exit signals to maximize returns.

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.